Anna Solini

51PUBLICATIONS
67CO-AUTHORS
Surface water quality processes and contaminated sediment assessmentMolecular targetsGlycoconjugatesMetabolic medicineEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jul 28, 2026
From Environmental Evidence to Biomarker Selection: A Structured Decision-Support Process for Human Biomonitoring Studies in Contaminated Sites.

|Jul 22, 2026
Mortality and persistence in therapy in elderly subjects with type 2 diabetes receiving gliflozins or incretins.

|Jan 22, 2026
Effect of SGLT2 Inhibitors + DPP-4 Inhibitors on Urine Microbiota in Type 2 Diabetes.

Marco Calvigioni, Edoardo Biancalana, Chiara Rossi

|Dec 31, 2025
Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes.

Samantha Pezzica, Filippo Pratesi, Silvia Sabatini

|Sep 24, 2025
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.

Gian Paolo Fadini, Enrico Longato, Sara Poletto

|Jul 02, 2025
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.

Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri

Pageof 9

Frequent Collaborators

6 joint publications

Chiara Rossi

6 joint publications

Domenico Tricò

5 joint publications

Giuseppe Pugliese

4 joint publications

Gian Paolo Fadini